Abbosh C, Frankell AM, Harrison T et al (2023) Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature 616(7957):553–562. https://doi.org/10.1038/s41586-023-05776-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arjuna S, Wang DH, Balar A et al (2024) CSF ctDNA analysis of patients with diffuse gliomas reveals diagnostic molecular alterations. Neuro-Oncol 26(suppl 8):3viii4. https://doi.org/10.1093/neuonc/noae165.0133

Article  Google Scholar 

Azad TD, Jin MC, Bernhardt LJ, Bettegowda C (2020) Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA. Neurosurg Focus 48(1):E9. https://doi.org/10.3171/2019.9.FOCUS19699

Article  PubMed  PubMed Central  Google Scholar 

Björkblom B, Wibom C, Eriksson M et al (2022) Distinct metabolic hallmarks of WHO classified adult glioma subtypes. Neuro Oncol 24(9):1454–1468. https://doi.org/10.1093/neuonc/noac042

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brat DJ, Aldape K, Colman H et al (2020) cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol 139(3):603–608. https://doi.org/10.1007/s00401-020-02127-9

Article  PubMed  PubMed Central  Google Scholar 

Chen X, Bai K, Zhang Y et al (2023) Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer. J Transl Med 21(1):296. https://doi.org/10.1186/s12967-023-04077-8

Article  PubMed  PubMed Central  CAS  Google Scholar 

Comba A, Faisal SM, Varela ML et al (2021) Uncovering spatiotemporal heterogeneity of high-grade gliomas: from disease biology to therapeutic implications. Front Oncol 11:703764. https://doi.org/10.3389/fonc.2021.703764

Article  PubMed  PubMed Central  CAS  Google Scholar 

Danilenko M, Clifford SC, Schwalbe EC (2021) Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma. Pharmacol Ther 228:107828. https://doi.org/10.1016/j.pharmthera.2021.107828

Article  PubMed  CAS  Google Scholar 

Douville C, Curtis S, Summers M et al (2023) Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid. Cell Rep Med 4(8):101148. https://doi.org/10.1016/j.xcrm.2023.101148

Article  PubMed  PubMed Central  CAS  Google Scholar 

Escudero L, Llort A, Arias A et al (2020) Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma. Nat Commun 11(1):5376. https://doi.org/10.1038/s41467-020-19175-0

Article  PubMed  PubMed Central  CAS  Google Scholar 

Greathouse KL, Sinha R, Vogtmann E (2019) DNA extraction for human microbiome studies: the issue of standardization. Genome Biol 20(1):212. https://doi.org/10.1186/s13059-019-1843-8

Article  PubMed  PubMed Central  Google Scholar 

Hickman RA, Miller AM et al (2024) Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors. Acta Neuropathol Commun 12(1):151. https://doi.org/10.1186/s40478-024-01846-4

Article  PubMed  PubMed Central  Google Scholar 

Hu LS, Hawkins-Daarud A, Wang L et al (2020) Imaging of intratumoral heterogeneity in high-grade glioma. Cancer Lett 477:97–106. https://doi.org/10.1016/j.canlet.2020.02.025

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jena A, Taneja S, Khan AA, Sogani SK (2021) Recurrent glioma: does qualitative simultaneous 18F-DOPA PET/mp-MRI improve diagnostic workup? Clin Nucl Med 46(9):703–709. https://doi.org/10.1097/RLU.0000000000003728

Article  PubMed  Google Scholar 

Klinsing S, Beck J, Weber KJ et al (2024) Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients. Acta Neuropathol Commun 12(1):177. https://doi.org/10.1186/s40478-024-01887-9

Article  PubMed  PubMed Central  CAS  Google Scholar 

Larson NB, Oberg AL, Adjei AA, Wang L (2023) A clinician’s guide to bioinformatics for next-generation sequencing. J Thorac Oncol 18(2):143–157. https://doi.org/10.1016/j.jtho.2022.11.006

Article  PubMed  CAS  Google Scholar 

Leach JL, Roebker J, Schafer A et al (2020) MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry. Neuro Oncol 22(11):1647–1657. https://doi.org/10.1093/neuonc/noaa140

Article  PubMed  PubMed Central  Google Scholar 

Lindblad C, Pin E, Just D et al (2021) Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study. Crit Care 25(1):103. https://doi.org/10.1186/s13054-021-03503-x

Article  PubMed  PubMed Central  Google Scholar 

Liu APY, Smith KS, Kumar R et al (2021) Serial assessment of measurable residual disease in medulloblastoma liquid biopsies. Cancer Cell 39(11):1519–1530. https://doi.org/10.1016/j.ccell.2021.09.012

Article  PubMed  PubMed Central  CAS  Google Scholar 

Louis DN, Wesseling P, Aldape K et al (2020) cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol 30(4):844–856. https://doi.org/10.1111/bpa.12832

Article  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  PubMed  PubMed Central  CAS  Google Scholar 

Martínez-Ricarte F, Mayor R, Martínez-Sáez E et al (2018) Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid. Clin Cancer Res 24(12):2812–2819. https://doi.org/10.1158/1078-0432

Article  PubMed  Google Scholar 

Mikolajewicz N, Yee P, Bhanja D et al (2024) Systematic review of cerebrospinal fluid biomarker discovery in neuro-oncology: a roadmap to standardization and clinical application. JCO 42(10):1961–1974. https://doi.org/10.1200/JCO.23.01621

Article  Google Scholar 

Miller AM, Shah RH, Pentsova EI et al (2019) Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature 565(7741):654–658. https://doi.org/10.1038/s41586-019-0882-3

Article  PubMed  PubMed Central  CAS  Google Scholar 

Miller AM, Szalontay L, Bouvier N et al (2022) Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients. Neuro Oncol 24(10):1763–1772. https://doi.org/10.1093/neuonc/noac035

Article  PubMed  PubMed Central  Google Scholar 

Muir M, Gopakumar S, Traylor J et al (2020) Glioblastoma multiforme: novel therapeutic targets. Expert Opin Ther Targets 24(7):605–614. https://doi.org/10.1080/14728222.2020.1762568

Article  PubMed  CAS  Google Scholar 

Orzan F, De Bacco F, Lazzarini E et al (2023) Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation. Clin Cancer Res 29(7):1252–1266. https://doi.org/10.1158/1078-0432

Article  PubMed  PubMed Central  CAS  Google Scholar